89 Ill. Adm. Code 2400.240.1543
Minimum Equipment Specifications for Automated Medication Dispenser Service
TITLE 89: SOCIAL SERVICES
CHAPTER II: DEPARTMENT ON AGING
PART 240 COMMUNITY CARE PROGRAM
SECTION 240.1543 MINIMUM EQUIPMENT SPECIFICATIONS FOR AUTOMATED MEDICATION DISPENSER SERVICE
Section 240.1543
Minimum Equipment Specifications for Automated Medication Dispenser Service
a) An AMD unit/equipment
must be capable of portability to be temporarily transferred to another
non-institutional residence in Illinois without additional fees.
b) AMD Unit Specifications
1) The AMD unit must be a
portable mechanical system configured with:
A) all the cords and
interfaces needed for installation;
B) an internal battery:
i) capable of operating as
a power source for a minimum of three years;
ii) that automatically charges
whenever the base unit is powered; and
iii) maintains a charge for
at least 12 hours when the electric power to the base unit is interrupted;
C) the ability to verify
whether the batteries on the base unit are charged and when the battery charge is
low;
D) components certified as
appropriate by the Federal Communications Commission (FCC) under 47 CFR 15 and
68;
E) appropriate Underwriters
Laboratories (UL) safety standards (UL 60950 and 60950-1) certification for
battery powered technology equipment;
F) an integrated unit that
connects to either a telephone line or wireless/cellular system that does not
interfere with the normal use of the telephone or other devices using the
telephone line, such as Emergency Home Response Service;
G) an Underwriters
Laboratory (UL) approved plug as the connector to a standard residential
electrical outlet for its power supply; and
H) transmission capability
to signal the support center or notify the participant/authorized
representative/assisting party if the base unit battery fails or has a low
charge, or if electric power to the base unit is interrupted.
2) The AMD unit must have
the following operating features:
A) ability to be loaded,
programmed and changed to add and remove medications, including:
i) local or remote programming
accessibility;
ii) medication dispensed at
least four times a day; and
iii) alerting the
participant at the times programmed for dispensing medication;
B) ability to be filled with
medications, including:
i) holding at least seven
days' supply of medications;
ii) holding multiple
medications in individual compartments;
iii) access to medication
for an early dose option; and
iv) locking after the
medication is loaded;
C) ability to alert the
participant when it is time to take medications at least every five to ten
minutes for at least 60 minutes until the dose is taken or the dose is locked,
including:
i) using verbal, auditory
or visual prompts such as flashing lights and audible tones or verbal
instructions, which may also provide messages to take medication that cannot be
stored in the machine (e.g., take medications with food; time to take insulin)
based on the individual's needs; and
ii) dispensing medications
at the correct time of day in the correct combinations and in the correct
quantities;
D) use privacy-protected and
secure methods of communication with the participant/authorized representative/assisting
party, including:
i) notification when
battery is low or unit is jammed, or if the participant has not taken the
medication within 90 minutes after the prescribed time;
ii) contact by the unit or support
center to the participant/authorized representative/assisting party to assure
adherence or needed intervention; and
E) ability to securely
transmit information and provide data to the participant/authorized representative/responsible
party, the Department or its designees.
3) The AMD unit must be
capable of conducting automatic battery testing and transmitting the results
through the AMD unit to the support center on an ongoing basis.
4) If an AMD unit is a
Class I medical device, the AMD unit is subject to the General Controls
mandated by the Federal Food and Drug Administration, including provisions that
relate to adulteration (21 U.S.C. 351); misbranding (21 U.S.C. 352); device
registration and listing (21 U.S.C. 360); notification, including repair,
replacement, or refund (21 U.S.C. 360h); records and reports (21 U.S.C. 360i);
and restricted devices (21 U.S.C. 520(e)). In addition, the manufacturer of
the device must fulfill requirements under 21 CFR 820.180 (Record keeping) and
820.198 (Complaint files). If an AMD unit has enhanced features, such as
remote capability, it may be classified as a Class II medical device and must
then meet applicable Special Controls under the FDA.
5) The AMD unit must have
adaptations for operation by participants who have functional, hearing or
visual impairments, and language barriers at no extra cost to the participants.
c) Support Center
Specifications
1) The AMD support center
must have back-up monitoring capacity to take over all medication dispenser
notification functions, monitoring and technical support functions.
2) The AMD back-up
monitoring center must be at a location different from the primary center, on a
different power grid system, and on a different telephone trunk line. It must
have a back-up battery and electrical generating capacity, as well as telephone
line and wireless/cellular system monitoring abilities. If the back-up center
is in the same city as the support center, the AMD provider must provide
assurances that back-up can be maintained in the event of a natural disaster.
3) All AMD support center
and back-up center equipment, at a minimum, must:
A) monitor the AMD system
for the receipt of incoming signals from an installed and programmed AMD unit
in a participant's residence, including missed medication doses, power
interruptions and outages, and test transmissions and fault conditions, on a
continuous basis;
B) direct an appropriate
response to the receipt of a signal immediately via texts/emails to the assisting
party and other designees and call the assisting party and other designees within
90 minutes after missed medications and within eight hours after power
interruptions and outages;
C) provide technical support
as required, 24 hours a day, 365 days a year;
D) identify each participant
and simultaneously record all communication between the participant/authorized representative/assisting
party and the support center, as applicable, for all signals, including missed
medication doses, test transmissions and fault conditions;
E) display, print and
archive the individual identifier, date, time, communication and response for
each signal, test and fault condition, which must be maintained for at least a three-year
period of time for quality control and liability purposes;
F) have an uninterruptible
power supply back-up that will automatically take over system operation in the
event electric power to the support center is interrupted, other type of
malfunction occurs, or repairs are needed. The back-up power supply must be
sufficient to operate the entire system for a minimum of seven calendar days;
G) have separate and
independent primary and back-up systems, computer servers, databases, and other
components to provide an uninterruptible monitoring system in the event of
equipment malfunction;
H) perform self-diagnostic
testing for malfunctions in the unit/equipment in a participant's residence
and at the support center, and for fault conditions in the primary and back-up
operating systems and power supply at the support center, that could interfere
with receiving and responding to signals, such as non-operational AMD units,
messages sent from the AMD unit to the participant/authorized representative/assisting
party or designees without confirmation of receipt, telephone line outages,
power loss, etc.;
I) capability to centrally
generate medication compliance data and reports as requested by the Department;
J) have quality management
systems that include tracking and trending of data, response times and
dispositions; and
K) maintain appropriate
certification by the FCC under 47 CFR 15 and 68, if applicable.